Appropriate Use Criteria
Showing 1 - 25 of >10,000
Appropriateness of Carpal Tunnel Syndrome Management Compared
Not yet recruiting
- Carpal Tunnel Syndrome
- Comparing the appropriateness of our practice and the usability of the AUC through comparing the actual management provided at our institution with that recommended by the AUC.
- (no location specified)
Mar 10, 2022
Community-acquired Pneumonia, Acute Otitis Media, Pharyngitis Trial in Philadelphia (Mixed methods intervention)
Recruiting
- Community-acquired Pneumonia
- +2 more
- Mixed methods intervention
-
Philadelphia, Pennsylvania
- +1 more
Sep 6, 2023
Ultrasonic Weaning Criteria in Prolonged Ventilation
Completed
- Acute Respiratory Distress Syndrome
- clinical weaning criteria
-
Ta'if, Saudi ArabiaKing abd el Aziz specialist hospital
Mar 31, 2023
COPD Trial in Birmingham (In Check Dial test)
Withdrawn
- Chronic Obstructive Pulmonary Disease
- In Check Dial test
-
Birmingham, AlabamaUAB Department of Medicine, Pulmonary Division
Aug 25, 2022
Antimicrobial Resistance Trial ("SteWARdS Antibiotic Defense" app)
Recruiting
- Antimicrobial Resistance
- "SteWARdS Antibiotic Defense" app
-
Singapore, SingaporeAng Mo Kio Polyclinic
Jan 5, 2023
PRetest prObability of Infectious ENDOCARDITIS for Appropriate
Completed
- Infective Endocarditis
- Transesophageal Echocardiography
-
Essen, NRW, GermanyUniversity Hospital Essen
Oct 7, 2021
Normal Human ImmunoGlobulins: Feasibility of Integrating
Not yet recruiting
- Immunoglobulins
- NHIg prescription
- (no location specified)
Aug 30, 2023
Palliative Care, Terminal Care, Medication Therapy Management Trial in Netherlands (CDSS-OPTIMED)
Recruiting
- Palliative Care
- +4 more
- CDSS-OPTIMED
-
Alkmaar, Netherlands
- +6 more
Aug 18, 2022
Assistance in Acute GEriatric Medicine
Completed
- Old Age
- Criteria for Screening and Triaging to Appropriate aLternative care
-
Toulouse, FranceUniversity Hospital Toulouse
Jan 31, 2022
E-Cig Use Trial (E-liquid coolant (WS-3, 0.1%), E-liquid coolant (WS-3, 0.25%), E-liquid coolant (WS-3, 0.5%))
Not yet recruiting
- E-Cig Use
- E-liquid coolant (WS-3, 0.1%)
- +9 more
- (no location specified)
Jun 28, 2023
Cancer Trial in Kufstein (Patient-reported outcomes assessment, CTCAE rating, PRO data is displayed)
Recruiting
- Cancer
- Patient-reported outcomes assessment
- +2 more
-
Kufstein, AustriaBezirkskrankenhaus Kufstein
Apr 5, 2022
Uterine Niche Following Different Caesarean Section Techniques:a
Recruiting
- Appropriate Diagnostic Criteria of Uterine Niche With Detection of Prevalence , Risk Factors and Associated Symptomes
-
Sohag, EgyptAbdelraman Fasial
Jun 13, 2021
Proposed Rotational Deformities a Useful Resource
Not yet recruiting
- Lower Limb Deformity
- +3 more
- Gait analysis
- (no location specified)
Oct 10, 2022
Genital Prolapse, Pessary, Satisfaction Trial in Caen (pessary use)
Recruiting
- Genital Prolapse
- +2 more
- pessary use
-
Caen, FrancePizzoferato
Aug 30, 2021
Appropriate Use Criteria, Coronary Revascularization Trial in Beijing
Completed
- Appropriate Use Criteria
- Coronary Revascularization
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 18, 2018
Asthma Trial in Taoyuan (Correct/recheck strategy, Usual verbal instruction)
Recruiting
- Asthma
- Correct/recheck strategy
- Usual verbal instruction
-
Taoyuan, TaiwanDepartment of Thoracic Medicine, Chang Gung Memorial Hospital
Jan 9, 2021
Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Immune Response of
Not yet recruiting
- Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
- +6 more
- ChulaCov19 BNA159 mRNA vaccine
-
Bangkok, Thailand
- +1 more
Nov 30, 2022
Complete Denture, Complete Edentulism Trial in Pathum Wan (denture adhesive (Polident®, GlaxoSmithKline, Ireland))
Completed
- Complete Denture
- Complete Edentulism
- denture adhesive (Polident®, GlaxoSmithKline, Ireland)
-
Pathum Wan, Bangkok, ThailandFaculty of Dentistry, Chulalongkorn University
Jun 23, 2021
Quality of Life, Drug Use Trial in Versailles (STOPP/START criteria)
Completed
- Quality of Life
- Drug Use
- STOPP/START criteria
-
Versailles, FranceHôpital La Porte Verte
Aug 4, 2020
Drug Use Trial in Doha (comprehensive multi-component interventions)
Recruiting
- Drug Use
- comprehensive multi-component interventions
-
Doha, QatarPHCC
Nov 14, 2023
Neurodegenerative Diseases, Stroke Trial in Messina (treatment and screening by neuropsychological tests on humanoid robot)
Completed
- Neurodegenerative Diseases
- Stroke
- treatment and screening by neuropsychological tests on humanoid robot
-
Messina, ItalyIRCCS Centro Neurolesi "Bonino-Pulejo"
Mar 27, 2023
Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Recruiting
- Sarcoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
-
Beijing, ChinaPeking University People's Hospital
Nov 6, 2023
Coronary Artery Stenosis Trial in Germany, Netherlands (PTCA - Desolve Scaffold)
Terminated
- Coronary Artery Stenosis
- PTCA - Desolve Scaffold
-
Bad Nauheim, Germany
- +4 more
Apr 23, 2021
Information and Communication Technologies for Health Support in
Recruiting
- Inflammatory Bowel Diseases
- +3 more
- QUECOMIICAT survey
- +3 more
-
Buenos Aires, ArgentinaMiguel Angel Puga Tejada
May 19, 2021
Health Behavior, Healthy Lifestyle Trial in Messina (ACT MINDFULNESS)
Completed
- Health Behavior
- Healthy Lifestyle
- ACT MINDFULNESS
-
Messina, ItalyIRCCS Centro Neurolesi "Bonino-Pulejo"
Mar 24, 2023